« Addressing Metabolic Dysfunction‑Associated Steatotic Liver Disease (MASLD) in Endocrinology Settings in Canada: From Prevalence to Patient-Centered Management », Can Diabetes Endocrinol Today, vol. 3, nᵒ s01, p. 2–8, déc. 2025, doi: 10.58931/cdet.2025.3s0144.